Concerns of patients with inflammatory bowel disease: results from a clinical populationElizabeth C. De Rooy, Zane Cohen, David Baron et al.|The American Journal of Gastroenterology|2001Cited by 135
<i>In Silico</i> Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicidal Ideation and Substance Use DisorderAlireza Sharafshah, Kenneth Blum, Kai-Uwe Lewandrowski et al.|Current Neuropharmacology|2025Cited by 9